Provention (PRVB) Price Target $18.

Headline Says Downgrade, But That's Near 300% Higher From Here! LIVE QUOTE Provention Bio (NASDAQ:PRVB) PT Lowered to $18.00 (MarketBeat). July 7th: Provention Bio (NASDAQ:PRVB - Get Rating) had its...

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become familiar with the trials that fail to...
ehave

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its...

Covid Vaccines and ‘Emergency Use’ Authorization Explained.

David Dodd discussing COVID-19 Vaccines and 'Emergency Use' Authorization https://youtu.be/Ppx8gQyYj8s?si=ACG31q97BSIBif4z&t=30 EMERGENCY USE AUTHORIZATION EXPLAINED https://www.youtube.com/embed/iGkwaESsGBQ FDA is globally respected for its scientific standards of vaccine safety, effectiveness and...

Ohio State University Completes Study on Pressure Bioscience (PBIO) and Protein Drinks.

Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market. Recent Study Published by The Ohio...

Revive’s Quarterly Report, Discussion, and a Video!

With 5,000 hospitalizations reported daily (150,000 a month), contracting Covid is not something to be taken lightly - after you get it. Unless of...
Revive Therapeutics

Revive Therapeutics Gains 25% on Positive FDA Comments.

The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and agree on...

Bavarian Nordic (BVNRY) Bags $119 Million Order from Joe Biden.

We Were up 80% on Bavarian For a Little While There. The Stock Looks Better Today, Then When we Originally Added to Watch List....

Could Bucillamine be the Key to Preventing Lockdowns in Places Like North Korea?

Revive Therapeutics Nears FDA-EUA Approval or Non-approval, for Bucillamine its Novel Anti-inflammatory and Antioxidant. Bucillamine 'Boosts' Glutathione, a Natural Substance Found in Virtually all...

Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...

- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days - - Results to be presented at PSYCH Symposium taking...

Latest article

Annette L. Redmond Joins Strategic Advisory Board at Sekur Private Data (SWISF).

Former U.S. State Department Deputy Assistant Secretary Decorated intelligence and cybersecurity executive with four decades of U.S. government leadership joins Sekur to advise on secure...

10X Alerts: Sekur Private Data (SWISF) Pushes SekurOne Closer to Market With First International...

Sekur has completed its first domestic and international encrypted calls on SekurOne and launched the platform’s voice, email, messenger, and VPN capabilities on Android...

Could a Record El Niño Ignite the Next Vaccine Trade?

Chikungunya, Dengue Fever, Rift Valley Fever and Zika The Coming El Niño: An Overlooked Catalyst for Vaccine Stocks? Investors obsess over interest rates, tariffs and AI....